Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers

The ongoing outbreak of the novel coronavirus disease 2019 (COVID-19), induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a significant toll on people and countries all over the world. The pathogenesis of COVID-19 has not been completely elucidated yet. This includes...

Full description

Bibliographic Details
Published in:	Microorganisms
Main Authors:	Mai M. Zafer, Hadir A. El-Mahallawy, Hossam M. Ashour
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Subjects:	COVID-19 sepsis cytokines SARS-CoV-2
Online Access:	https://www.mdpi.com/2076-2607/9/1/159

Similar Items

The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes
by: Andrea Piccioni, et al.
Published: (2023-09-01)

Oxidative stress parameters and inflammatory and immune mediators as markers of the severity of sepsis
by: Isil Bavunoglu, et al.
Published: (2016-10-01)

Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis
by: Chao Ren, et al.
Published: (2020-08-01)

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression
by: Jesús Beltrán-García, et al.
Published: (2020-09-01)

Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption
by: Juan Carlos Ruiz-Rodríguez, et al.
Published: (2022-04-01)

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
by: Sara De Biasi, et al.
Published: (2023-05-01)

Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State
by: Andreas Limmer, et al.
Published: (2023-02-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress
by: Naama Karu, et al.
Published: (2022-07-01)

Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
by: Nicole L Messina, et al.
Published: (2022-01-01)

Parallel Dysregulated Immune Response in Severe Forms of COVID-19 and Bacterial Sepsis via Single-Cell Transcriptome Sequencing
by: Alexis Garduno, et al.
Published: (2023-03-01)

Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection
by: Nathalie Rohmann, et al.
Published: (2022-10-01)

Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients
by: Ihtzaz Ahmed Malik, et al.
Published: (2022-03-01)

Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity?
by: Fernando A Bozza, et al.
Published: (2005-03-01)

Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
by: Allison B. Chambliss, et al.
Published: (2023-08-01)

Sepsis, leukocytes, cytokines and disseminated intravascular coagulation
by: Ramazan Çöl, et al.

Infection, Inflammation, and Immunity in Sepsis
by: Undurti N. Das
Published: (2023-08-01)

Effects of Glucocorticoid Therapy on Sepsis Depend Both on the Dose of Steroids and on the Severity and Phase of the Animal Sepsis Model
by: Ye Jin Park, et al.
Published: (2022-03-01)

Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients
by: Adrian Krygier, et al.
Published: (2022-12-01)

Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19
by: Renuka Roche, et al.
Published: (2023-07-01)

SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion
by: Angela Quirino, et al.
Published: (2021-12-01)

Immune correction in patients with sepsis (literature review)
by: A. V. Stepanov, et al.
Published: (2024-04-01)

Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
by: Mieke A. van der Mescht, et al.
Published: (2025-02-01)

Marcadores humorales en la sepsis severa Humoral markers in severe sepsis
by: Alfredo Sánchez Valdivia, et al.
Published: (2006-12-01)

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
by: Faheem Hyder Pottoo, et al.
Published: (2021-02-01)

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
by: Xi Li, et al.
Published: (2024-06-01)

COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males
by: Wendy Fonseca, et al.
Published: (2021-12-01)

Immunological criteria for the diagnosis of multisystem inflammatory syndrome associated with MERS-COV-2 and infectious diseases with sepsis in children
by: Yu. E. Konstantinovа, et al.
Published: (2024-12-01)

Host-Based Treatments for Severe COVID-19
by: Lucrezia Mondini, et al.
Published: (2023-04-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
by: Leland Shapiro, et al.
Published: (2023-10-01)

From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis
by: Zhi Liu, et al.
Published: (2024-08-01)

Genetic polymorphisms associated with sepsis incidence, severity, and outcomes among neonates: A mini-review
by: Darnifayanti Darnifayanti, et al.
Published: (2023-01-01)

The Importance of the Concentration of Selected Cytokines (IL-6, IL-10, IL-12, IL-15, TNF-α) and Inflammatory Markers (CRP, NLR, PLR, LMR, SII) in Predicting the Course of Rehabilitation for Patients after COVID-19 Infection
by: Alicja Mińko, et al.
Published: (2024-09-01)

Characteristics of cytokines/chemokines associated with disease severity and adverse prognosis in COVID-19 patients
by: Jianghao Cheng, et al.
Published: (2024-11-01)

Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
by: Sunhee Lee, et al.
Published: (2022-10-01)

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
by: Helena Codina, et al.
Published: (2021-10-01)

Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans
by: Alexandra Schäfer, et al.
Published: (2024-06-01)

Immune-related pathogenesis of COVID-19 andprevention and treatment strategies
by: Sun Zhibing, et al.
Published: (2021-06-01)

The Many Faces of Innate Immunity in SARS-CoV-2 Infection
by: Nicholas Hanan, et al.
Published: (2021-06-01)